Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BIOCUDET

Financiado

Cerrado

Identify and detect key ocular biomarkers towards personal medicine

In the EU, the costs of ocular diseases amount to 70% of the costs induced by cancer. This is bound to increase as our population ages, especially as most costs result from late or wrong diagnosis. The current ocular disease diagn... ver más

28/09/2018

ELVESYS

89K€

Presupuesto del proyecto: 89K€

Líder del proyecto

ELVESYS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-09-28

INNOSUP-02-2016: European SME innovation Associate -...

I+D

Cerrada hace 8 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ELVESYS

89.38K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PARCIVAL Partner Network for a Clinically Validated Multi Analyte Lab... 4M€ Cerrado

VIRTUALVIALS Virtual vials for enhanced biomolecular analysis 777K€ Cerrado

MULTIDET Multiplex qPCR detection and chemical analysis towards multi... 88K€ Cerrado

SCOPE CRISPR Point-of-Care Diagnostics Cerrado

RAPP-ID Development of RApid Point-of-Care test Platforms for Infect... 16M€ Cerrado

PoC-Cycle Innovative Molecular Diagnostics point of care device for MR... 71K€ Cerrado

Duración del proyecto: 13 meses Fecha Inicio: 2017-08-14
Fecha Fin: 2018-09-28

Líder del proyecto

ELVESYS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 89K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In the EU, the costs of ocular diseases amount to 70% of the costs induced by cancer. This is bound to increase as our population ages, especially as most costs result from late or wrong diagnosis. The current ocular disease diagnostic devices are far from delivering the expected performance. The concomitant discovery of biomarker candidates for several major eye diseases and development of fast multiplex quantitative PCR (qPCR) technology offers the unique opportunity to propose a Point of Care Test (PoCT) able to fulfil modern ocular diagnostics needs. By hiring an Innovation Associate with an expertise in ophthalmology and microbiology, ELVESYS wants to develop the first fast and affordable biomarker based PoCT device for the ocular disease diagnostics market. This system will enable any practitioner to propose a diagnosis based on the simultaneous measurement of ocular disease biomarkers in less than 10 minutes. This system will offer the capacity of simultaneous diagnosis of main ocular diseases in a single test during the time of a visit to the doctor’s office. The Innovation Associate will benefit from ELVESYS expertise in the world fastest multiplex qPCR system and OPIA expertise of conjunctiva sampling to develop this first prototype. The BIOCUDET project is today the most relevant in the world to bring a PoCT system to the market within the next couple of years to address with success this major social and economic concern. This system will give ELVESYS the highest competitive advantage on a global total admissible market of €3.5 billion per year by 2025. This PoCT is today the key solution to alleviate the medical and social issues of ocular diseases that weighs more than €86 billion annually on the EU healthcare systems. This project will also allow ELVESYS to train an Innovation Associate in entrepreneurship so that they can later become part of the team or start their own spin-off company to commercialize the PoCT system developed.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores